Hepatocellular adenoma

Hepatocellular adenoma
Classification and external resources

Micrograph of a hepatic adenoma (bottom of image). H&E stain.
ICD-O: M8170/0
DiseasesDB 5726
eMedicine med/48
MeSH D018248

Hepatocellular adenoma, also hepatic adenoma, or rarely hepadenoma, is an uncommon benign liver tumor which is associated with the use of hormonal contraception with a high estrogen content.[1] Patients taking higher potency hormones, patients of advanced age, or patients with prolonged duration of use have a significantly increased risk of developing hepatocellular adenomas.[2]

Contents

Diagnosis

MRI is the most useful investigation in the diagnosis and work-up.[3] CT may also be used to diagnose hepatic adenomas.

Large hepatic adenomas have a tendency to rupture and bleed massively inside the abdomen.

Radiologic differential diagnosis

Pathologic diagnosis

Hepatic adenoma are, typically, well-circumscribed nodules that consist of sheets of hepatocytes with a bubbly vacuolated cytoplasm. The hepatocytes are on a regular reticulin scaffold and less or equal to three cell thick.

The histologic diagnosis of hepatic adenomas can be aided by reticulin staining. In hepatic adenomas, the reticulin scaffold is preserved and hepatocytes do not form layers of four or more hepatocytes, as is seen in hepatocellular carcinoma.

Cells resemble normal hepatocytes and are traversed by blood vessels but lack portal tracts or central veins.

Etiology

Ninety percent of hepatic adenomas arise in women aged 20–40, most of whom use oral contraceptives.

Related Conditions

Hepatic adenomas are related to glycogen storage diseases, type 1, as well as anabolic steroids.

Treatment

Some authors feel that all hepatocellular adenoma should be resected, because of the risk of rupture causing bleeding and because they may contain malignant foci.[4]. However, the majority of experts feel that lesions less than 5 cm should merely be observed with serial imaging. Patients with adenomas should avoid oral contraceptives or hormonal replacement therapy.

Additional images

References

  1. ^ Rooks J, Ory H, Ishak K, Strauss L, Greenspan J, Hill A, Tyler C (1979). "Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.". JAMA 242 (7): 644–8. doi:10.1001/jama.242.7.644. PMID 221698. 
  2. ^ "Hepatocellular Adenoma: eMedicine Gastroenterology". http://emedicine.medscape.com/article/170205-overview. 
  3. ^ Hussain S, van den Bos I, Dwarkasing R, Kuiper J, den Hollander J (2006). "Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis.". Eur Radiol 16 (9): 1873–86. doi:10.1007/s00330-006-0292-4. PMID 16708218. 
  4. ^ Toso C, Majno P, Andres A, Rubbia-Brandt L, Berney T, Buhler L, Morel P, Mentha G (2005). "Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors.". World J Gastroenterol 11 (36): 5691–5. PMID 16237767. Full text

External links